Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Monika Anna Niewczas, Ph.D., M.D.


Harvard T.H. Chan School of Public Health, BostonMPH05/2018Clinical Effectiveness

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DK123459 (NIEWCZAS, MONIKA ANNA) Apr 30, 2020 - Feb 28, 2025
    Understanding the role of the Complement Proteome in progressive Diabetic Kidney Disease
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jones TLZ, Holmes CM, Katona A, Martin CL, Niewczas MA, Pop-Busui R, Schmidt BM, Sen CK, Tomic-Canic M, Veves A. The NIDDK Diabetic Foot Consortium. J Diabetes Sci Technol. 2022 Sep 03; 19322968221121152. PMID: 36059271.
    Citations:    Fields:    
  2. Kobayashi H, Looker HC, Satake E, D'Addio F, Wilson JM, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Badger HS, Petrazzuolo A, Corradi D, Galecki A, Wilson PC, Najafian B, Mauer M, Niewczas MA, Doria A, Humphreys BD, Duffin KL, Fiorina P, Nelson RG, Krolewski AS. Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes. Sci Transl Med. 2022 08 10; 14(657):eabj2109. PMID: 35947673; PMCID: PMC9531292.
    Citations:    Fields:    Translation:Humans
  3. Shah HS, Moreno LO, Morieri ML, Tang Y, Mendonca C, Jobe JM, Thacker JB, Mitri J, Monti S, Niewczas MA, Pennathur S, Doria A. Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies. Diabetes Care. 2022 08 01; 45(8):1882-1892. PMID: 35696261; PMCID: PMC9346986.
    Citations:    Fields:    
  4. Theocharidis G, Rahmani S, Lee S, Li Z, Lobao A, Kounas K, Katopodi XL, Wang P, Moon S, Vlachos IS, Niewczas M, Mooney D, Veves A. Murine macrophages or their secretome delivered in alginate dressings enhance impaired wound healing in diabetic mice. Biomaterials. 2022 09; 288:121692. PMID: 35934520.
    Citations: 1     Fields:    Translation:AnimalsCells
  5. Kobayashi H, Looker HC, Satake E, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Galecki AT, Niewczas MA, Wilson JM, Doria A, Duffin KL, Nelson RG, Krolewski AS. Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes. Kidney Int. 2022 08; 102(2):370-381. PMID: 35618095; PMCID: PMC9333266.
    Citations:    Fields:    Translation:Humans
  6. Satake E, Saulnier PJ, Kobayashi H, Gupta MK, Looker HC, Wilson JM, Md Dom ZI, Ihara K, O'Neil K, Krolewski B, Pipino C, Pavkov ME, Nair V, Bitzer M, Niewczas MA, Kretzler M, Mauer M, Doria A, Najafian B, Kulkarni RN, Duffin KL, Pezzolesi MG, Kahn CR, Nelson RG, Krolewski AS. Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes. J Am Soc Nephrol. 2021 09; 32(9):2331-2351. PMID: 34140396; PMCID: PMC8729832.
    Citations: 5     Fields:    Translation:Humans
  7. Loretelli C, Rocchio F, D'Addio F, Ben Nasr M, Castillo-Leon E, Dellepiane S, Vergani A, Abdelsalam A, Assi E, Maestroni A, Usuelli V, Bassi R, Pastore I, Yang J, El Essawy B, Elased KM, Fadini GP, Ippolito E, Seelam AJ, Pezzolesi M, Corradi D, Zuccotti GV, Gallieni M, Allegretti M, Niewczas MA, Fiorina P. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease. Metabolism. 2021 08; 121:154804. PMID: 34097917.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  8. Kaminska J, Stopinski M, Mucha K, Pac M, Golebiowski M, Niewczas MA, Paczek L, Foroncewicz B. Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality. Int J Gen Med. 2021; 14:2413-2420. PMID: 34135625; PMCID: PMC8200134.
    Citations: 3     
  9. Moon S, Tsay JJ, Lampert H, Md Dom ZI, Kostic AD, Smiles A, Niewczas MA. Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration. Sci Rep. 2021 04 21; 11(1):8592. PMID: 33883567; PMCID: PMC8060327.
    Citations: 1     Fields:    Translation:Humans
  10. Kobayashi S, Thelin MA, Parrish HL, Deshpande NR, Lee MS, Karimzadeh A, Niewczas MA, Serwold T, Kuhns MS. A biomimetic five-module chimeric antigen receptor (5MCAR) designed to target and eliminate antigen-specific T cells. Proc Natl Acad Sci U S A. 2020 11 17; 117(46):28950-28959. PMID: 33139567.
    Citations: 6     Fields:    Translation:AnimalsCells
  11. Ihara K, Skupien J, Krolewski B, Md Dom ZI, O'Neil K, Satake E, Kobayashi H, Rashidi NM, Niewczas MA, Krolewski AS. A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders. Kidney Int. 2021 03; 99(3):725-736. PMID: 32717193.
    Citations: 5     Fields:    Translation:Humans
  12. Gordin D, Shah H, Shinjo T, St-Louis R, Qi W, Park K, Paniagua SM, Pober DM, Wu IH, Bahnam V, Brissett MJ, Tinsley LJ, Dreyfuss JM, Pan H, Dong Y, Niewczas MA, Amenta P, Sadowski T, Kannt A, Keenan HA, King GL. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy. Diabetes Care. 2019 07; 42(7):1263-1273. PMID: 31076418.
    Citations: 28     Fields:    Translation:HumansCells
  13. Niewczas MA, Pavkov ME, Skupien J, Smiles A, Md Dom ZI, Wilson JM, Park J, Nair V, Schlafly A, Saulnier PJ, Satake E, Simeone CA, Shah H, Qiu C, Looker HC, Fiorina P, Ware CF, Sun JK, Doria A, Kretzler M, Susztak K, Duffin KL, Nelson RG, Krolewski AS. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat Med. 2019 05; 25(5):805-813. PMID: 31011203.
    Citations: 101     Fields:    Translation:Humans
  14. Kaminska J, Stopinski M, Mucha K, Jedrzejczak A, Golebiowski M, Niewczas MA, Paczek L, Foroncewicz B. IL 6 but not TNF is linked to coronary artery calcification in patients with chronic kidney disease. Cytokine. 2019 08; 120:9-14. PMID: 30991230.
    Citations: 19     Fields:    Translation:Humans
  15. Satake E, Pezzolesi MG, Md Dom ZI, Smiles AM, Niewczas MA, Krolewski AS. Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes. Diabetes. 2018 05; 67(5):1013-1023. PMID: 29453204; PMCID: PMC5910001.
    Citations: 33     Fields:    Translation:HumansCells
  16. Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int. 2018 05; 93(5):1198-1206. PMID: 29398132; PMCID: PMC5911430.
    Citations: 40     Fields:    Translation:Humans
  17. Niewczas MA, Krolewski AS. Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390. Diabetes Care. 2017 08; 40(8):e109-e110. PMID: 28733381.
    Citations:    Fields:    Translation:Humans
  18. Qi W, Keenan HA, Li Q, Ishikado A, Kannt A, Sadowski T, Yorek MA, Wu IH, Lockhart S, Coppey LJ, Pfenninger A, Liew CW, Qiang G, Burkart AM, Hastings S, Pober D, Cahill C, Niewczas MA, Israelsen WJ, Tinsley L, Stillman IE, Amenta PS, Feener EP, Vander Heiden MG, Stanton RC, King GL. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 2017 Jun; 23(6):753-762. PMID: 28436957; PMCID: PMC5575773.
    Citations: 147     Fields:    Translation:HumansAnimalsCells
  19. Yamanouchi M, Skupien J, Niewczas MA, Smiles AM, Doria A, Stanton RC, Galecki AT, Duffin KL, Pullen N, Breyer MD, Bonventre JV, Warram JH, Krolewski AS. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. Kidney Int. 2017 07; 92(1):258-266. PMID: 28396115; PMCID: PMC5796779.
    Citations: 20     Fields:    Translation:Humans
  20. Niewczas MA, Mathew AV, Croall S, Byun J, Major M, Sabisetti VS, Smiles A, Bonventre JV, Pennathur S, Krolewski AS. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care. 2017 Mar; 40(3):383-390. PMID: 28087576.
    Citations: 37     Fields:    Translation:Humans
  21. Bassi R, Niewczas MA, Biancone L, Bussolino S, Merugumala S, Tezza S, D'Addio F, Ben Nasr M, Valderrama-Vasquez A, Usuelli V, De Zan V, El Essawy B, Venturini M, Secchi A, De Cobelli F, Lin A, Chandraker A, Fiorina P. Metabolomic Profiling in Individuals with a Failing Kidney Allograft. PLoS One. 2017; 12(1):e0169077. PMID: 28052095.
    Citations: 13     Fields:    Translation:Humans
  22. Nowak N, Skupien J, Niewczas MA, Yamanouchi M, Major M, Croall S, Smiles A, Warram JH, Bonventre JV, Krolewski AS. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int. 2016 Feb; 89(2):459-67. PMID: 26509588; PMCID: PMC4848189.
    Citations: 52     Fields:    Translation:Humans
  23. Pavkov ME, Weil EJ, Fufaa GD, Nelson RG, Lemley KV, Knowler WC, Niewczas MA, Krolewski AS. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int. 2016 Jan; 89(1):226-34. PMID: 26398493; PMCID: PMC4805514.
    Citations: 29     Fields:    Translation:HumansCells
  24. Prudente S, Shah H, Bailetti D, Pezzolesi M, Buranasupkajorn P, Mercuri L, Mendonca C, De Cosmo S, Niewczas M, Trischitta V, Doria A. Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes. 2015 Jul; 64(7):2658-63. PMID: 25677913; PMCID: PMC4477355.
    Citations: 15     Fields:    Translation:Humans
  25. Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int. 2015 Apr; 87(4):812-9. PMID: 25272234.
    Citations: 57     Fields:    Translation:Humans
  26. Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, Bassi R, D'Addio F, Schatton T, Abdi R, Atkinson M, Sayegh MH, Wen L, Wasserfall CH, O'Connor KC, Fiorina P. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes. 2015 Jan; 64(1):158-71. PMID: 25187361; PMCID: PMC4274804.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  27. Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS. Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. Diabetes Care. 2014 Sep; 37(9):2601-8. PMID: 24898299.
    Citations: 24     Fields:    Translation:Humans
  28. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29. PMID: 24676639.
    Citations: 58     Fields:    Translation:HumansAnimalsCells
  29. Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J, Karoly ED, Kensicki EM, Berry GT, Bonventre JV, Pennathur S, Meyer TW, Krolewski AS. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 2014 May; 85(5):1214-24. PMID: 24429397.
    Citations: 93     Fields:    Translation:Humans
  30. Krolewski AS, Gohda T, Niewczas MA. Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes. Clin Exp Nephrol. 2014 Aug; 18(4):571-83. PMID: 24218296.
    Citations: 12     Fields:    Translation:HumansAnimals
  31. Qi L, Qi Q, Prudente S, Mendonca C, Andreozzi F, di Pietro N, Sturma M, Novelli V, Mannino GC, Formoso G, Gervino EV, Hauser TH, Muehlschlegel JD, Niewczas MA, Krolewski AS, Biolo G, Pandolfi A, Rimm E, Sesti G, Trischitta V, Hu F, Doria A. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013 Aug 28; 310(8):821-8. PMID: 23982368; PMCID: PMC3858847.
    Citations: 55     Fields:    Translation:HumansCells
  32. Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. 2014; 37(1):226-34. PMID: 23939543.
    Citations: 115     Fields:    Translation:Humans
  33. Lee JE, Gohda T, Walker WH, Skupien J, Smiles AM, Holak RR, Jeong J, McDonnell KP, Krolewski AS, Niewczas MA. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS One. 2013; 8(3):e58007. PMID: 23526964; PMCID: PMC3603950.
    Citations: 18     Fields:    Translation:Humans
  34. Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS. Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline. PLoS One. 2013; 8(3):e57751. PMID: 23505438.
    Citations: 4     Fields:    Translation:HumansCells
  35. Merchant ML, Niewczas MA, Ficociello LH, Lukenbill JA, Wilkey DW, Li M, Khundmiri SJ, Warram JH, Krolewski AS, Klein JB. Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int. 2013 Jun; 83(6):1177-84. PMID: 23466993.
    Citations: 22     Fields:    Translation:HumansAnimalsCells
  36. Vergani A, Tezza S, D'Addio F, Fotino C, Liu K, Niewczas M, Bassi R, Molano RD, Kleffel S, Petrelli A, Soleti A, Ammirati E, Frigerio M, Visner G, Grassi F, Ferrero ME, Corradi D, Abdi R, Ricordi C, Sayegh MH, Pileggi A, Fiorina P. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation. 2013 Jan 29; 127(4):463-75. PMID: 23250993; PMCID: PMC3569513.
    Citations: 48     Fields:    Translation:HumansAnimalsCells
  37. Doria A, Niewczas MA, Fiorina P. Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? Semin Nephrol. 2012 Sep; 32(5):437-44. PMID: 23062984.
    Citations: 15     Fields:    Translation:Humans
  38. Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG, Cantarovich D, Stanton R, Krolewski AS. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int. 2012 Sep; 82(5):589-97. PMID: 22622493.
    Citations: 60     Fields:    Translation:Humans
  39. Perkins BA, Rabbani N, Weston A, Ficociello LH, Adaikalakoteswari A, Niewczas M, Warram J, Krolewski AS, Thornalley P. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. PLoS One. 2012; 7(4):e35655. PMID: 22558190.
    Citations: 26     Fields:    Translation:Humans
  40. Gohda T, Walker WH, Wolkow P, Lee JE, Warram JH, Krolewski AS, Niewczas MA. Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes. Am J Physiol Renal Physiol. 2012 Jul 01; 303(1):F157-62. PMID: 22513848.
    Citations: 11     Fields:    Translation:Humans
  41. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012 Mar; 23(3):516-24. PMID: 22266664.
    Citations: 169     Fields:    Translation:HumansCells
  42. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012 Mar; 23(3):507-15. PMID: 22266663.
    Citations: 217     Fields:    Translation:HumansCells
  43. Engelmann P, Farkas K, Kis J, Richman G, Zhang Z, Liew CW, Borowiec M, Niewczas MA, Jalahej H, Orbán T. Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol. 2011 Aug; 23(8):473-84. PMID: 21708895.
    Citations: 8     Fields:    Translation:HumansCells
  44. Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol. 2011 Mar; 22(3):545-53. PMID: 21355053.
    Citations: 90     Fields:    Translation:Humans
  45. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-ß-D-glucosaminidase. Kidney Int. 2011 Feb; 79(4):464-70. PMID: 20980978.
    Citations: 102     Fields:    Translation:Humans
  46. Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 2010 Jun; 33(6):1337-43. PMID: 20332356; PMCID: PMC2875450.
    Citations: 87     Fields:    Translation:Humans
  47. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2009 Jan; 4(1):62-70. PMID: 19073786.
    Citations: 70     Fields:    Translation:HumansCells
  48. Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, Krolewski AS. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract. 2008 Nov 13; 82 Suppl 1:S46-53. PMID: 18849087.
    Citations: 16     Fields:    Translation:Humans
  49. Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, Warram JH, Krolewski AS. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008 May; 3(3):706-13. PMID: 18272826; PMCID: PMC2386694.
    Citations: 62     Fields:    Translation:HumansCells
  50. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol. 2008 Apr; 19(4):789-97. PMID: 18256362.
    Citations: 68     Fields:    Translation:Humans
  51. Juskowa J, Lewandowska M, Bartlomiejczyk I, Foroncewicz B, Korabiewska I, Niewczas M, Sierdzinski J. Physical rehabilitation and risk of atherosclerosis after successful kidney transplantation. Transplant Proc. 2006 Jan-Feb; 38(1):157-60. PMID: 16504691.
    Citations: 9     Fields:    Translation:Humans
  52. Ziolkowski J, Paczek L, Senatorski G, Niewczas M, Oldakowska-Jedynak U, Wyzgal J, Sanko-Resmer J, Pilecki T, Zieniewicz K, Nyckowski P, Patkowski W, Krawczyk M. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc. 2003 Sep; 35(6):2307-9. PMID: 14529923.
    Citations: 5     Fields:    Translation:Humans
  53. Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-Jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-Wroblewska B, Gornicka B. Acute liver transplant rejection: incidence and the role of high-doses steroids. Transplant Proc. 2003 Sep; 35(6):2289-91. PMID: 14529918.
    Citations: 2     Fields:    Translation:Humans
  54. Ziolkowski J, Niewczas M, Senatorski G, Zygier D, Oldakowska-Jedynak U, Wyzgal J, Michalska W, Niemczyk M, Zieniewicz K, Nyckowski P, Alsharabi A, Hevelke P, Krawczyk M, Górnicka B, Ziarkiewicz-Wróblewska B, Paczek L. Liver transplantation in hepatitis C virus-related cirrhosis. Transplant Proc. 2003 Sep; 35(6):2275-7. PMID: 14529913.
    Citations:    Fields:    Translation:Humans
  55. Patkowski W, Nyckowski P, Zieniewicz K, Pawlak J, Michalowicz B, Kotulski M, Smoter P, Grodzicki M, Skwarek A, Ziolkowski J, Oldakowska-Jedynak U, Niewczas M, Paczek L, Krawczyk M. Biliary tract complications following liver transplantation. Transplant Proc. 2003 Sep; 35(6):2316-7. PMID: 14529926.
    Citations: 6     Fields:    Translation:Humans
  56. Oldakowska-Jedynak U, Niewczas M, Ziolkowski J, Mucha K, Foroncewicz B, Bartlomiejczyk I, Senatorski G, Wyzgal J, Krawczyk M, Zieniewicz K, Nyckowski P, Paczek L. Cytomegalovirus infection as a common complication following liver transplantation. Transplant Proc. 2003 Sep; 35(6):2295-7. PMID: 14529920.
    Citations: 2     Fields:    Translation:Humans
  57. Zieniewicz K, Skwarek A, Nyckowski P, Pawlak J, Michalowicz B, Patkowski W, Najnigier B, Alsharabi A, Hevelke P, Remiszewski P, Smoter P, Dudek K, Grodzicki M, Paczkowska A, Oldakowska-Jedynak U, Niewczas M, Paczek L, Krawczyk M. Comparison of the results of liver transplantation for elective versus urgent indications. Transplant Proc. 2003 Sep; 35(6):2262-4. PMID: 14529908.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  58. Krawczyk M, Grzelak I, Zieniewicz K, Nyckowski P, Pawlak J, Michalowicz B, Patkowski W, Alsharabi A, Wróblewski T, Paluszkiewicz R, Malkowski P, Hevelke P, Pszenny C, Remiszewski P, Skwarek A, Smoter P, Grodzicki M, Kornasiewicz O, Korba M, Kotulski M, Dudek K, Fraczek M, Najnigier B, Alzayany M, Paczkowska A, Gelo R, Andruszkiewicz P, Sicinski M, Jurek-Gelo A, Swierczewski J, Giercuszkiewicz D, Brudkowska A, Andrzejewska R, Niewinski G, Nowak R, Kosinski C, Korta T, Oldakowska-Jedynak U, Sanko-Resmer J, Pawlowska M, Foroncewicz B, Ziólkowski J, Niewczas M, Mucha K, Senatorski G, Paczek L, Leowska E, Pacho R, Andrzejewska M, Rowinski O, Zurakowski J, Wróblewska B, Górnicka B. The impact of experience of a transplantation center on the outcomes of orthotopic liver transplantation. Transplant Proc. 2003 Sep; 35(6):2268-70. PMID: 14529910.
    Citations:    Fields:    Translation:Humans
  59. Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-Jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-Wroblewska B, Gornicka B. Effect of immunosuppressive regimen on acute rejection and liver graft function. Transplant Proc. 2003 Sep; 35(6):2281-3. PMID: 14529915.
    Citations: 1     Fields:    Translation:Humans
  60. Wyzgal J, Oldakowska-Jedynak U, Paczek L, Michalska M, Ziolkowski J, Soluch L, Zygier D, Sanko-Resmer J, Gradowska L, Niewczas M, Galazka Z, Pacholczyk M, Durlik M. Posttransplantation diabetus mellitus under calcineurin inhibitor. Transplant Proc. 2003 Sep; 35(6):2216-8. PMID: 14529893.
    Citations: 4     Fields:    Translation:Humans
  61. Senatorski G, Paczek L, Kropiewnicka E, Wyzgal J, Pilecki T, Zegarska J, Niewczas M. [Noninvasive monitoring of chronic glomerulonephritides progression]. Pol Merkur Lekarski. 2002 Nov; 13 Suppl 1:21-6; discussion 26-7. PMID: 12621777.
    Citations:    Fields:    Translation:Humans
  62. Niewczas M, Paczek L, Krawczyk M, Pawlak J, Bartlomiejczyk I, Górnicka B. [Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma]. Pol Arch Med Wewn. 2002 Jul; 108(1):653-62. PMID: 12412410.
    Citations: 1     Fields:    Translation:Humans
  63. Niewczas M, Ziólkowski J, Rancewicz Z, Szymanska K, Kwiatkowski A, Galazka T, Senatorski G, Paczek L. Tuberculosis in patients after renal transplantation remains still a clinical problem. Transplant Proc. 2002 Mar; 34(2):677-9. PMID: 12009662.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Niewczas's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (276)
Co-Authors (39)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.